title: EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
authors.affiliation: Universitaetsklinikum Tuebingen, Medizinische Klinik Abteilung II, Otfried-Mueller St 10, D-72076 Tuebingen, Germany. carsten.bokemeyer@med.uni-tuebingen.de
authors.forename: C
authors.initials: C
authors.lastname: Bokemeyer
authors.forename: M S
authors.initials: MS
authors.lastname: Aapro
authors.forename: A
authors.initials: A
authors.lastname: Courdi
authors.forename: J
authors.initials: J
authors.lastname: Foubert
authors.forename: H
authors.initials: H
authors.lastname: Link
authors.forename: A
authors.initials: A
authors.lastname: Osterborg
authors.forename: L
authors.initials: L
authors.lastname: Repetto
authors.forename: P
authors.initials: P
authors.lastname: Soubeyran
mesh_terms: D000740:Anemia / Q000209:etiology / Q000517:prevention & control*; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006973:Hypertension / Q000209:etiology; D009369:Neoplasms / Q000150:complications*; D011788:Quality of Life; D016019:Survival Analysis; D013923:Thromboembolism / Q000209:etiology
chemical_list: D004921:Erythropoietin